Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin

In this report, we present a 37‐year‐old woman with villous cancer who developed AKI after co‐administration of VCM and TAZ/PIPC. Trough concentration of VCM reach a toxic level. Finally, she recovered on day 17.[Image: see text]

Detalles Bibliográficos
Autores principales: Nakatani, Kaori, Momo, Kenji, Mimura, Takashi, Yoshiizumi, Eri, Sasaki, Tadanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347319/
https://www.ncbi.nlm.nih.gov/pubmed/35937011
http://dx.doi.org/10.1002/ccr3.6081
Descripción
Sumario:In this report, we present a 37‐year‐old woman with villous cancer who developed AKI after co‐administration of VCM and TAZ/PIPC. Trough concentration of VCM reach a toxic level. Finally, she recovered on day 17.[Image: see text]

Ejemplares similares